Premium
Bisphosphonate use in conditions other than osteoporosis
Author(s) -
Silverman Stuart L.
Publication year - 2011
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1111/j.1749-6632.2010.05769.x
Subject(s) - medicine , osteoporosis , bisphosphonate , osteogenesis imperfecta , periprosthetic , juvenile dermatomyositis , bone density conservation agents , teriparatide , surgery , bone density , disease , bone mineral , pathology , arthroplasty
Bisphosphonates are the gold standard of treatment of postmenopausal osteoporosis, male osteoporosis, and steroid‐induced osteoporosis. They have potential use in multiple musculoskeletal conditions other than osteoporosis and have also been shown to treat Paget's disease of the bone and osteogenesis imperfecta. Bisphophonates may have potential use in periprosthetic bone loss, osteonecrosis of the hip, fibrous dysplasia, and calcinosis in juvenile dermatomyositis.